Provided by Tiger Trade Technology Pte. Ltd.

Weight Loss Drugs

1,732.83
+9.260.54%
Number of Gainers:7
Number of Losers:- -
Number of Flat:- -
PE:- -
High:1,748.21
Open:1,722.53
Low:1,718.91
Close:1,723.57
Volume:30.71M
Turnover:2.55B
Market Cap:1.80T
Float Cap:1.73T

Loading ...

More US Employers to Drop Weight-Loss Drugs in 2027, as Healthcare Costs Increase

Reuters
·
12 mins ago

Lilly’s LY4395089 Interaction Study Marks Quiet but Important Early-Stage Progress

TIPRANKS
·
1 hour ago

Novo Nordisk price target raised to DKK 275 from DKK 250 at JPMorgan

TIPRANKS
·
2 hours ago

Novo Nordisk call volume above normal and directionally bullish

TIPRANKS
·
Yesterday

FDA Greenlights Roche and Eli Lilly's Blood-Based Alzheimer's Test, Setting a Single Threshold to Rule Both In and Out Amyloid Pathology

Deep News
·
Yesterday

Political and General News Events from August 25

Reuters
·
Yesterday

Stick with Value Stocks Until Everyone Starts Talking About Them - and as of Now They're Still Under the Radar, This Wall Street Firm Says

Dow Jones
·
Yesterday

Novo Nordisk Sales Growth Could Remain Flat This Year

Dow Jones
·
Yesterday

Press Release: Septerna Appoints Industry Veteran Rajiv Patni, M.D., as Chief Medical Officer

Dow Jones
·
Yesterday

Novo Nordisk (0QIU) Receives a Hold from Deutsche Bank

TIPRANKS
·
Yesterday

J.P. Morgan Sticks to Its Hold Rating for Novo Nordisk (0QIU)

TIPRANKS
·
Yesterday

Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and Eli Lilly & Co (LLY)

TIPRANKS
·
Yesterday

Amgen Inc. Stock Underperforms Monday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Yesterday

Eli Lilly Stock (LLY) in Focus as Hedge Fund Titan Ken Griffin Quadruples Position

TIPRANKS
·
Yesterday

Der Aktionaer editor speculates on timing of Viking Therapeutics data

TIPRANKS
·
Yesterday

Sector Update: Healthcare

MT Newswires Live
·
Yesterday

Novo Nordisk’s AMAZE 9 Oral Obesity Trial: A New Pill in the Weight-Loss Race

TIPRANKS
·
Yesterday

Amgen Extends MariTide Study In Obesity And Diabetes, Keeping Investor Focus On Long-Term Potential

TIPRANKS
·
Yesterday

Eli Lilly’s New Obesity Drug LY3549492 Moves Forward With Completed Phase 1 Trial

TIPRANKS
·
Yesterday

Novo Nordisk A/S Series B Stock Falls Monday, Underperforms Market

Dow Jones
·
Yesterday